Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, April 1, 2014

WSJ Live - $1,000-a-Day Hepatitis C Drug Is a Blockbuster

WSJ Live

$1,000-a-Day Hepatitis C Drug Is a Blockbuster
Runaway demand for a life-saving hepatitis C treatment that costs $1,000 a day could send insurers' earnings per share down by double-digit percentages this year. Jonathan Rockoff reports on Lunch Break.



No comments:

Post a Comment